Survey: Biotech execs consider practical qualities in Big Pharma tie-ups

03/23/2011 | In Vivo Blog

Most biotech companies prefer looking at large drugmakers' practical characteristics, such as their clinical and sales and marketing capabilities, before forging alliances with such firms, according to a 2010 survey conducted by the Boston Consulting Group. The report also noted that Roche Holding and Merck & Co. are among the big drugmakers that performed the best when it comes to key categories biotech executives consider in making partnerships. These qualities include deal structure flexibility, responsiveness and manufacturing expertise.

View Full Article in:

In Vivo Blog

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX